HIV and refractory anemia with excess blasts (RAEB)

American Journal of Hematology

Volumn 70, Issue 4, 2002, Pages 318-319

  Modest, Geoffrey A ^a,b   Cooley, Timothy P ^a   Zacks, Jeff F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Upham's Corner Health Center   (United States)

Author keywords

AIDS; HIV; Myelodysplastic syndrome; Refractory anemia with excess blasts

Indexed keywords

EFAVIRENZ; LAMIVUDINE; STAVUDINE;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADULT; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALE; OXAZINES; PANCYTOPENIA; PNEUMONIA; STAVUDINE; TREATMENT OUTCOME;

EID: 0036330440     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10113     Document Type: Article

References (3)

1. Refractory anemia with excess of blasts in a HIV-positive patient
2. Classification and morphologic features of the myelodysplastic syndromes
3. Myelodysplastic syndromes: A clinical and pathologic analysis of 109 cases